CLARITHROMYCINE EG 500 mg, modified-release film-coated tablet 5 tablets
Active ingredients: Clarithromycin
Commercialized according to BDPMDispensing in France: Prescription only
Modified-release film-coated tablet5 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLARITHROMYCINE EG 500 mg, comprimé pelliculé à libération modifiée
- Pharmaceutical form
- comprimé pelliculé à libération modifiée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 5 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Dec 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61966605CIP73000437CIP133400930004371Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CLARITHROMYCINEcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.